• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

小儿重症支原体肺炎的儿科危重病评分、临床特征及综合治疗

Pediatric Critical Illness Score, Clinical Characteristics and Comprehensive Treatment of Children with Severe Mycoplasma Pneumoniae Pneumonia.

作者信息

Fang Chengchao, Mao Yueyan, Jiang Mingfen, Yin Wei

机构信息

Department of Pediatrics, The First People's Hospital of Linping District, Hangzhou, China.

Hemodialysis center, The First People's Hospital of Linping District, Hangzhou, China.

出版信息

Front Surg. 2022 May 25;9:897550. doi: 10.3389/fsurg.2022.897550. eCollection 2022.

DOI:10.3389/fsurg.2022.897550
PMID:35693303
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9174934/
Abstract

OBJECTIVE

To investigate the clinical characteristics of children with severe Mycoplasma pneumoniae pneumonia (SMPP) and the correlation with pediatric critical illness score (PICS), and to explore the effect of combined treatment with antibiotics and glucocorticoids.

METHODS

The medical records of 120 children with SMPP admitted to our hospital from January 2020 to June 2021 were retrospectively analyzed. Children with a PICS score greater than 80 within 24 h of admission were included in the non-critical group, those with a score of 71-80 were included in the critical group, and those with a score of ≤70 were included in the extremely critical group. The relevant clinical data and examination indicators of the three groups of children were intercepted and compared. Univariate and multifactorial logistic regression analyses were performed to analyze the correlation between clinical characteristics of children with SMPP and PICS. According to the different treatment methods, the children were subdivided into the control group ( = 54) who received antibiotics alone and the comprehensive group ( = 66) who received antibiotics combined with glucocorticoid therapy. The erythrocyte sedimentation rate (ESR), inflammation and immune indexes, symptom relief or disappearance time, hospitalization days, and clinical efficacy were compared between the two groups before and after treatment.

RESULT

Within 24 h of admission, among the 120 children with SMPP, 79 had PICS >80, 32 had PICS 71-80, and 9 had PICS ≤70. Before discharge, among the 120 children with SMPP, 99 had PICS >80, 17 had PICS 71-80, and 4 had PICS ≤70. Univariate analysis showed that there were no significant differences in gender ratio, ratio of fever duration >10 days, age and WBC among the three groups (> 0.05), the differences in the ratio of abnormal ECG, the ratio of ≥2 pathogenic infections, the ratio of ≥2 systemic damages, CRP levels, and D-dimer levels were statistically significant when compared among the three groups (< 0.05). Multivariate Logistic regression analysis showed that the number of Co-systemic damages and the level of D-dimer were negatively correlated with PICS classification (< 0.05). After medication, ESR, CRP, IL-6, and CD8+ levels decreased and CD4+ and CD4+/CD8+ levels increased in both the control and comprehensive groups, and all changes were significant in the comprehensive group compared with the control group (< 0.05). The antipyretic time, cough relief time, disappearance time of lung rales and hospitalization days in the comprehensive group were shorter than those in the control group (< 0.05). The total effective rate of the comprehensive group (95.45%) was better than that of the control group (83.33%) (< 0.05).

CONCLUSION

PICS can effectively reflect the clinical characteristics of children with SMPP. The comprehensive treatment effect of azithromycin combined with glucocorticoid is significantly better than that of azithromycin alone. It can effectively reduce the level of inflammation in children with SMPP, improve the immune function of children, and accelerate clinical recovery. It has promotion value.

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd3c/9174934/2af7b4a48b1f/fsurg-09-897550-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd3c/9174934/e8c263caa2f1/fsurg-09-897550-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd3c/9174934/ccff1feffee4/fsurg-09-897550-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd3c/9174934/e61f2f407aca/fsurg-09-897550-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd3c/9174934/2af7b4a48b1f/fsurg-09-897550-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd3c/9174934/e8c263caa2f1/fsurg-09-897550-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd3c/9174934/ccff1feffee4/fsurg-09-897550-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd3c/9174934/e61f2f407aca/fsurg-09-897550-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd3c/9174934/2af7b4a48b1f/fsurg-09-897550-g004.jpg
摘要

目的

探讨重症肺炎支原体肺炎(SMPP)患儿的临床特征及其与小儿危重病评分(PICS)的相关性,并探究抗生素联合糖皮质激素治疗的效果。

方法

回顾性分析2020年1月至2021年6月我院收治的120例SMPP患儿的病历资料。入院24小时内PICS评分大于80分的患儿纳入非危重组,评分71 - 80分的患儿纳入危重组,评分≤70分的患儿纳入极危重组。截取并比较三组患儿的相关临床资料及检查指标。进行单因素和多因素logistic回归分析,以分析SMPP患儿临床特征与PICS的相关性。根据治疗方法不同,将患儿分为单纯接受抗生素治疗的对照组(n = 54)和接受抗生素联合糖皮质激素治疗的综合组(n = 66)。比较两组治疗前后的红细胞沉降率(ESR)、炎症及免疫指标、症状缓解或消失时间、住院天数及临床疗效。

结果

入院24小时内,120例SMPP患儿中,PICS>80分的有79例,PICS 71 - 80分的有32例,PICS≤70分的有9例。出院前,120例SMPP患儿中,PICS>80分的有99例,PICS 71 - 80分的有17例,PICS≤70分的有4例。单因素分析显示,三组患儿的性别比例、发热持续时间>10天的比例、年龄及白细胞计数差异无统计学意义(>0.05),三组间心电图异常比例、≥2种病原感染比例、≥2种全身损害比例、CRP水平及D - 二聚体水平差异有统计学意义(<0.05)。多因素logistic回归分析显示,合并全身损害数量及D - 二聚体水平与PICS分级呈负相关(<0.05)。用药后,对照组和综合组的ESR、CRP、IL - 6及CD8+水平均下降,CD4+及CD4+/CD8+水平均升高,且综合组与对照组相比,所有变化均有统计学意义(<0.05)。综合组的退热时间、咳嗽缓解时间、肺部啰音消失时间及住院天数均短于对照组(<0.05)。综合组的总有效率(95.45%)优于对照组(83.33%)(<0.05)。

结论

PICS能有效反映SMPP患儿的临床特征。阿奇霉素联合糖皮质激素的综合治疗效果明显优于单纯阿奇霉素治疗。可有效降低SMPP患儿的炎症水平,提高患儿免疫功能,加速临床康复。具有推广价值。

相似文献

1
Pediatric Critical Illness Score, Clinical Characteristics and Comprehensive Treatment of Children with Severe Mycoplasma Pneumoniae Pneumonia.小儿重症支原体肺炎的儿科危重病评分、临床特征及综合治疗
Front Surg. 2022 May 25;9:897550. doi: 10.3389/fsurg.2022.897550. eCollection 2022.
2
Prediction Model for Severe Mycoplasma pneumoniae Pneumonia in Pediatric Patients by Admission Laboratory Indicators.基于入院实验室指标预测儿科患者重症肺炎支原体肺炎的模型。
J Trop Pediatr. 2022 Jun 6;68(4). doi: 10.1093/tropej/fmac059.
3
D-dimer: The Risk Factor of Children's Severe Mycoplasma Pneumoniae Pneumonia.D-二聚体:儿童重症支原体肺炎的危险因素
Front Pediatr. 2022 Apr 12;10:828437. doi: 10.3389/fped.2022.828437. eCollection 2022.
4
Meta-analysis of the Clinical Efficacy and Safety of High- and Low-dose Methylprednisolone in the Treatment of Children With Severe Mycoplasma Pneumoniae Pneumonia.大剂量与小剂量甲泼尼龙治疗儿童重症肺炎支原体肺炎的临床疗效及安全性的 Meta 分析
Pediatr Infect Dis J. 2020 Mar;39(3):177-183. doi: 10.1097/INF.0000000000002529.
5
A prediction study of IL-18 and IFN-γ in glucocorticoid treatment response in infants and young children with severe pneumonia.婴幼儿重症肺炎糖皮质激素治疗反应中白细胞介素-18和干扰素-γ的预测研究
Transl Pediatr. 2022 May;11(5):738-747. doi: 10.21037/tp-22-139.
6
Pulmonary Thrombotic Complication of Mycoplasma pneumoniae Pneumonia in Chinese Children: Clinical Feature and Risk Factor Analysis.儿童肺炎支原体肺炎合并肺血栓栓塞症的临床特征及危险因素分析。
Pediatr Infect Dis J. 2024 Jun 1;43(6):505-510. doi: 10.1097/INF.0000000000004287. Epub 2024 Feb 15.
7
Optimization strategy for the early timing of bronchoalveolar lavage treatment for children with severe mycoplasma pneumoniae pneumonia.严重肺炎支原体肺炎患儿支气管肺泡灌洗治疗时机的优化策略。
BMC Infect Dis. 2023 Oct 5;23(1):661. doi: 10.1186/s12879-023-08619-9.
8
The Level of D-Dimer Is Positively Correlated With the Severity of Pneumonia in Children.D-二聚体水平与儿童肺炎的严重程度呈正相关。
Front Cell Infect Microbiol. 2021 Jul 15;11:687391. doi: 10.3389/fcimb.2021.687391. eCollection 2021.
9
Study on the Correlation Between the Expression of NF-Ƙb in the Alveolar Lavage Fluid of Children with Severe Mycoplasma Pneumoniae Pneumonia, Its Clinical Characteristics, and Cellular Immunity.重症肺炎支原体肺炎患儿肺泡灌洗液中NF-Ƙb表达与其临床特征及细胞免疫的相关性研究
Infect Drug Resist. 2024 Jun 19;17:2469-2484. doi: 10.2147/IDR.S411361. eCollection 2024.
10
Serum cytokine profiling reveals different immune response patterns during general and severe pneumonia.血清细胞因子谱分析揭示了普通型和重型肺炎期间不同的免疫反应模式。
Front Immunol. 2022 Dec 22;13:1088725. doi: 10.3389/fimmu.2022.1088725. eCollection 2022.

引用本文的文献

1
Effect analysis of flexible bronchoscopy in thoracoscopic surgery for congenital pulmonary airway malformation.软性支气管镜在先天性肺气道畸形胸腔镜手术中的效果分析
Medicine (Baltimore). 2025 Aug 1;104(31):e43635. doi: 10.1097/MD.0000000000043635.
2
Prediction model for severe mycoplasma pneumoniae pneumonia and analysis of macrolide-resistance in children: a case-control study.儿童重症肺炎支原体肺炎预测模型及大环内酯类耐药性分析:一项病例对照研究
Ital J Pediatr. 2025 Jun 7;51(1):180. doi: 10.1186/s13052-025-02039-y.
3
Effect of pulmonary rehabilitation nursing approach with integrated traditional Chinese and western medicine in children with Mycoplasma Pneumonia after Bronchoalveolar Lavage.

本文引用的文献

1
Dual-energy spectral CT imaging of pulmonary embolism with Mycoplasma pneumoniae pneumonia in children.儿童肺炎支原体肺炎合并肺栓塞的能谱 CT 双能量成像。
Radiol Med. 2022 Feb;127(2):154-161. doi: 10.1007/s11547-021-01442-9. Epub 2022 Jan 16.
2
C-reactive protein and clinical outcomes in patients with COVID-19.C 反应蛋白与 COVID-19 患者的临床结局。
Eur Heart J. 2021 Jun 14;42(23):2270-2279. doi: 10.1093/eurheartj/ehaa1103.
3
Monocyte-Independent and -Dependent Regulation of Regulatory T-Cell Development in Mycoplasma Infection.
中西医结合肺康复护理方法对支原体肺炎患儿支气管肺泡灌洗术后的影响
Pak J Med Sci. 2025 Apr;41(4):1105-1109. doi: 10.12669/pjms.41.4.9787.
4
Correlation analysis between the severity of respiratory syncytial virus pneumonia and the expression levels of inflammatory cytokines in bronchoalveolar lavage fluid among infants and young children.婴幼儿呼吸道合胞病毒肺炎严重程度与支气管肺泡灌洗液中炎症细胞因子表达水平的相关性分析
Front Pediatr. 2025 Feb 19;13:1482029. doi: 10.3389/fped.2025.1482029. eCollection 2025.
5
Clinical features of intracardiac thrombotic complication in patients with severe Mycoplasma pneumoniae pneumonia.重症支原体肺炎患者心内血栓形成并发症的临床特征
Ital J Pediatr. 2025 Feb 11;51(1):42. doi: 10.1186/s13052-025-01890-3.
6
Predictive value of plasma sB7-H3 and YKL-40 in pediatric refractory Mycoplasma pneumoniae pneumonia.血浆sB7-H3和YKL-40在小儿难治性支原体肺炎中的预测价值
Open Med (Wars). 2025 Jan 15;20(1):20241114. doi: 10.1515/med-2024-1114. eCollection 2025.
7
Factors based on Cox regression modeling to analyze the prognostic impact of fiberoptic bronchoscopic bronchoalveolar lavage on children with severe pneumonia.基于Cox回归模型的因素,以分析纤维支气管镜支气管肺泡灌洗对重症肺炎患儿的预后影响。
Am J Transl Res. 2024 Dec 15;16(12):7645-7655. doi: 10.62347/OGZD3131. eCollection 2024.
8
Diagnostic value of ultrasound for community-acquired pneumonia in children and its correlation with serum PCT level and PCIS.超声对儿童社区获得性肺炎的诊断价值及其与血清 PCT 水平和 PCIS 的相关性。
Medicine (Baltimore). 2024 Oct 25;103(43):e39590. doi: 10.1097/MD.0000000000039590.
9
Clinical Value of Coagulation Function Indicators in Children with Severe Pneumonia.凝血功能指标在重症肺炎患儿中的临床价值
Int J Gen Med. 2024 Oct 15;17:4659-4668. doi: 10.2147/IJGM.S478443. eCollection 2024.
10
Predicting the severity of mycoplasma pneumoniae pneumonia in pediatric and adult patients: a multicenter study.预测儿童和成年患者肺炎支原体肺炎严重程度的多中心研究。
Sci Rep. 2024 Oct 3;14(1):22978. doi: 10.1038/s41598-024-74251-5.
支原体感染中单核细胞非依赖性和依赖性调节性 T 细胞发育的调控。
J Infect Dis. 2021 May 28;223(10):1733-1742. doi: 10.1093/infdis/jiaa590.
4
Efficacy and safety of azithromycin combined with glucocorticoid on refractory Mycoplasma pneumoniae pneumonia in children: A PRISMA-compliant systematic review and meta-analysis.阿奇霉素联合糖皮质激素治疗儿童难治性支原体肺炎的疗效和安全性:一项遵循PRISMA标准的系统评价和Meta分析
Medicine (Baltimore). 2020 May 29;99(22):e20121. doi: 10.1097/MD.0000000000020121.
5
Mycoplasma pneumoniae pneumonia associated thrombosis at Beijing Children's hospital.北京儿童医院肺炎支原体肺炎相关性血栓形成。
BMC Infect Dis. 2020 Jan 16;20(1):51. doi: 10.1186/s12879-020-4774-9.
6
Pneumonia in Children and Adolescents.儿童和青少年肺炎
Pediatr Rev. 2020 Jan;41(1):12-19. doi: 10.1542/pir.2018-0016.
7
Mycoplasma pneumoniae-related hepatitis in children.儿童肺炎支原体相关性肝炎。
Microb Pathog. 2020 Feb;139:103863. doi: 10.1016/j.micpath.2019.103863. Epub 2019 Nov 9.
8
Clinical Utility of Procalcitonin in the Diagnosis of Pneumonia.降钙素原在肺炎诊断中的临床应用。
Clin Chem. 2019 Dec;65(12):1532-1542. doi: 10.1373/clinchem.2019.306787. Epub 2019 Oct 15.
9
The epidemiology of paediatric Mycoplasma pneumoniae pneumonia in North China: 2006 to 2016.华北地区儿童肺炎支原体肺炎的流行病学:2006 年至 2016 年。
Epidemiol Infect. 2019 Jan;147:e192. doi: 10.1017/S0950268819000839.
10
Necrotizing pneumonia caused by refractory Mycoplasma pneumonia pneumonia in children.儿童难治性肺炎支原体肺炎致坏死性肺炎。
World J Pediatr. 2018 Aug;14(4):344-349. doi: 10.1007/s12519-018-0162-6. Epub 2018 Jun 11.